Pacer Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,224
| Closed | -$269K | – | 3384 |
|
|
2025
Q1 | $269K | Buy |
+16,224
| New | +$269K | ﹤0.01% | 1655 |
|
|
2024
Q3 | – | Sell |
-1,735
| Closed | -$28.2K | – | 2529 |
|
|
2024
Q2 | $28.2K | Sell |
1,735
-87
| -5% | -$1.41K | ﹤0.01% | 3338 |
|
|
2024
Q1 | $33.7K | Buy |
+1,822
| New | +$33.7K | ﹤0.01% | 3325 |
|
|
2021
Q2 | – | Sell |
-2,882
| Closed | -$74K | – | 1396 |
|
|
2021
Q1 | $74K | Buy |
2,882
+298
| +12% | +$7.65K | ﹤0.01% | 1348 |
|
|
2020
Q4 | $138K | Buy |
2,584
+294
| +13% | +$15.7K | ﹤0.01% | 1300 |
|
|
2020
Q3 | $94K | Buy |
+2,290
| New | +$94K | ﹤0.01% | 1256 |
|
|
2018
Q4 | – | Sell |
-17,604
| Closed | -$365K | – | 532 |
|
|
2018
Q3 | $365K | Buy |
+17,604
| New | +$365K | 0.01% | 920 |
|
|
2018
Q1 | – | Sell |
-2,932
| Closed | -$88K | – | 1038 |
|
|
2017
Q4 | $88K | Sell |
2,932
-14,996
| -84% | -$450K | 0.01% | 968 |
|
|
2017
Q3 | $675K | Buy |
17,928
+2,618
| +17% | +$98.6K | 0.06% | 496 |
|
|
2017
Q2 | $427K | Buy |
15,310
+1,636
| +12% | +$45.6K | 0.04% | 699 |
|
|
2017
Q1 | $470K | Buy |
13,674
+2,480
| +22% | +$85.2K | 0.06% | 513 |
|
|
2016
Q4 | $323K | Buy |
11,194
+498
| +5% | +$14.4K | 0.05% | 648 |
|
|
2016
Q3 | $340K | Buy |
+10,696
| New | +$340K | 0.05% | 535 |
|